Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Robotic upper-limb therapy with built-in cognitive exercises for people with Parkinson's, MS, or stroke

Official title: Exploring Cognitive Recovery: the Impact of Sensor-based Robotic Rehabilitation in Neurological and Neurodegenerative Disorders

Run by IRCCS Centro Neurolesi Bonino Pulejo · NCT07384143 · Data updated 2026-11-12

This trial will test whether sensor-based robotic arm training that includes thinking exercises can help adults with Parkinson's disease, multiple sclerosis, or stroke improve attention, memory, and arm movement.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment189 (estimated)
SponsorIRCCS Centro Neurolesi Bonino Pulejo
Academic / other
Locations1 site (Messina, Maine)
StatusRecruiting
StartedFebruary 11, 2025
Main results expectedFebruary 11, 2030
Study endsFebruary 11, 2030
Registry record updatedFebruary 3, 2026
Trial IDNCT07384143 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–75 with Parkinson's disease, multiple sclerosis, or stroke who have upper-limb motor impairment within the FMA-UL 0–52 range and measurable cognitive impairment (MoCA ≤ 20) are the intended candidates.

Probably not a fit

People with severe cognitive, behavioral, or sensory disorders, or those outside the 18–75 age range, are unlikely to benefit or be eligible for this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

CROSS-ND is a randomized controlled trial comparing sensor-based robotic upper-limb rehabilitation with embedded cognitive tasks to conventional therapy in adults with neurological disorders. Participants are randomly assigned to the robotic/virtual-reality program or to standard therapy and complete 25 sessions over 2–3 months with intensity adapted to performance. Outcomes include disease-specific neuropsychological tests (ACE-R, BRB-N, RBANS) and motor measures (Fugl-Meyer Assessment, Nine Hole Peg Test) plus robotic device metrics collected at baseline and immediately after the intervention. The protocol targets simultaneous motor and cognitive training to promote neuroplasticity and functional independence.

Why it matters

Potential benefit: If successful, the combined robotic and cognitive approach could improve both thinking skills and arm function, helping participants perform daily tasks more independently.

How similar studies have gone: Previous robotic and VR rehabilitation studies have shown motor improvements and some cognitive gains, but integrating sensor-based robots with embedded cognitive tasks is a newer approach that has limited large-scale proof so far.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18-75 years;
* FMA-UL 0-31: eligible for exoskeletons and robotic devices with high support. (Armeo Power, Amadeo, Motore)
* FMA-UL 32-47: eligible for end-effectors with medium support. (Armeo Spring, Hand Tutor, Diego)
* FMA-UL 48-52: eligible for sensor-based with low support. (Pablo, Diego, Armeo Senso)
* MoCA: ≤ 20

Exclusion Criteria:

* Severe cognitive disorders
* Behavioral disorders
* Sensory disorders

Where it's running

  • IRCCS Centro Neurolesi Bonino-Pulejo
    Messina, Maine, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.